Coeliac Disease: Clinical Trials

2 trials for Coeliac Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1

Follow Coeliac Disease: new trials by email Literature Review of Coeliac Disease trials Research Report on Coeliac Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
Amlitelimab, Placebo, SIGE - Coeliac Disease, Celiac Disease
Phase 2Active not recruitingSanofi2292024-08-292026-08-31
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
KAN-101, Placebo - Celiac Disease, Coeliac Disease
Phase 2CompletedKanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA552023-12-132025-12-18

Narrower conditions

Celiac Disease (2)

Broader conditions

Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Malabsorption Syndromes (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Sponsors

Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA (1)  ·  Sanofi (1)

Countries

Canada (2)  ·  Finland (2)  ·  Germany (2)  ·  Israel (2)  ·  Netherlands (2)  ·  Poland (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Chile (1)  ·  Czechia (1)  ·  France (1)  ·  Greece (1)